Dual TTK/CLK2 inhibitor, CC‐671, selectively antagonizes ABCG2‐mediated multidrug resistance in lung cancer cells - 肿瘤精准医学与个性化用药研究团队 | LabXing

array(2) { ["lab"]=> string(4) "1347" ["publication"]=> string(5) "11804" } Dual TTK/CLK2 inhibitor, CC‐671, selectively antagonizes ABCG2‐mediated multidrug resistance in lung cancer cells - 肿瘤精准医学与个性化用药研究团队 | LabXing

肿瘤精准医学与个性化用药研究团队

简介

关注

Dual TTK/CLK2 inhibitor, CC‐671, selectively antagonizes ABCG2‐mediated multidrug resistance in lung cancer cells

2020

期刊 Cancer Science

作者 Zhuo-Xun Wu · Yuqi Yang · Guangsuo Wang · Jing-Quan Wang · Qiu-Xu Teng · Lingling Sun · Zi-Ning Lei · Lizhu Lin · Zhe-Sheng Chen · Chang Zou

下载全文

卷 111
期 8
页码 2872-2882
Wiley
ISSN: 1347-9032
DOI: 10.1111/cas.14505

LabXing 上可以免费创建课题组网站